Psyence Biomedical Tumbles On Heels Of Trump Executive Order - Psyence Biomedical (NASDAQ:PBM)
Summary
Psyence Biomedical stock faces profit-taking on Tuesday after a massive rally fueled by a Trump executive order and news on ibogaine supply.
Description
Psyence Biomedical stock faces profit-taking on Tuesday after a massive rally fueled by a Trump executive order and news on ibogaine supply.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source